Benign prostatic hyperplasia: pathophysiology and pharmacological treatment

Recent studies have confirmed that a-blocker therapy and antihormonal therapy are effective and safe treatment modalities in patients with symptomatic benign prostatic hyperplasia. New data suggest that the clinical response to medical therapy lasts for at least 3 years without any increase in side...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Current opinion in nephrology and hypertension 1995-09, Vol.4 (5), p.455-459
Hauptverfasser:	Madsen, Finn A, Bruskewitz, Reginald C
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenergic alpha-Antagonists - therapeutic use Enzyme Inhibitors - therapeutic use Finasteride - therapeutic use Humans Male Prostatic Hyperplasia - drug therapy Prostatic Hyperplasia - physiopathology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Recent studies have confirmed that a-blocker therapy and antihormonal therapy are effective and safe treatment modalities in patients with symptomatic benign prostatic hyperplasia. New data suggest that the clinical response to medical therapy lasts for at least 3 years without any increase in side effects during this period.
ISSN:	1062-4821 1473-6543
DOI:	10.1097/00041552-199509000-00015